Pharmacokinetics of a liposomal formulation of doxorubicin in rats.

about

Pharmacokinetics of a liposomal formulation of doxorubicin in rats.

Item

http://www.wikidata.org/entity/Q41815740

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Pharmacokinetics of a liposomal formulation of doxorubicin in rats.

@en

type

Item

label

Pharmacokinetics of a liposomal formulation of doxorubicin in rats.

@en

prefLabel

Pharmacokinetics of a liposomal formulation of doxorubicin in rats.

@en

P1476

Pharmacokinetics of a liposomal formulation of doxorubicin in rats.

@en

P2093

Fei Hao

http://www.w3.org/2001/XMLSchema#string

Jiahui Lu

http://www.w3.org/2001/XMLSchema#string

Jing Xie

http://www.w3.org/2001/XMLSchema#string

Qingfan Meng

http://www.w3.org/2001/XMLSchema#string

Robert J Lee

http://www.w3.org/2001/XMLSchema#string

Yaping Tian

http://www.w3.org/2001/XMLSchema#string

Yating Sun

http://www.w3.org/2001/XMLSchema#string

Ye Bi

http://www.w3.org/2001/XMLSchema#string

Zongyu Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Doxorubicin cardiomyopathy

Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation.

Treatment of intermediate-stage hepatocellular carcinoma.

Emerging delivery systems to reduce doxorubicin cardiotoxicity and improve therapeutic index: focus on liposomes.

The anthracycline antineoplastic drugs.

Pharmacokinetics of liposome-encapsulated antitumor drugs and implications for therapy.

Nephroprotective Effect of the Leaves of Aloe barbadensis (Aloe Vera) against Toxicity Induced by Diclofenac Sodium in Albino Rabbits.

Determination of free and liposomal amphotericin B in human plasma by liquid chromatography-mass spectroscopy with solid phase extraction and protein precipitation techniques.

Separation and determination of liposomal and non-liposomal daunorubicin from the plasma of patients treated with Daunoxome.

Simultaneous measurement of doxorubicin and reduced metabolite doxorubicinol by UHPLC-MS/MS in human plasma of HCC patients treated with TACE.

P304

531-536

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JSPS.2017.04.019

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28579888

http://www.w3.org/2001/XMLSchema#string

P932

5447445

http://www.w3.org/2001/XMLSchema#string